The Empty Capsules Market is segmented byProduct Type (Gelatin Capsules and Non-gelatin Capsules), by Functionality Type (Immediate-release Capsules, Delayed-release Capsules, and Sustained-release Capsules), by Application Type (Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Cardiovascular Therapy Drugs, and Others), by End-User Type (Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Industry, Research Laboratories, Others) andby Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The U.K., Russia, and Rest of Europe], Asia-Pacific [China, Japan, India, South Korea, and Rest of Asia-Pacific], and Rest of the World [Brazil, Saudi Arabia, Israel, and Others]).
The Empty Capsules Market is segmented by Product Type ...
“The Empty Capsules Market was estimated at US$ 2.64 billion in 2021 and is expected to grow at a CAGR of 7.22% during 2022-2028 to reach US$ 4.31 billion in 2028”.
Empty capsules are pharmaceutical and dietary supplement delivery shells made of materials like gelatin or plant-based substances. Empty capsules can be used to conceal the flavor of cardiac treatment medications, preventing nausea in the patient. If a result, as the prevalence of CVDs rises, so will the demand for cardiac treatment medications.
This element may have a favorable impact on the market for empty capsules. Empty capsules come in various sizes, colors, and compositions, offering versatility and customization for different medication and supplement needs.
Market Drivers
A rise in the popularity of capsules over other drug delivery forms, as well as an increase in strategic alliances between empty capsule providers and gelatin manufacturers, are major factors driving market expansion. Furthermore, the world's expanding senior population raises the demand for various therapeutic medications and nutritional supplements to improve health results.
According to the United Nations, World Ageing Population: the 2020 Revision, nearly 1.5 billion people will be over 65 years old by 2050, up from 727 million in 2020. Furthermore, rapid improvements in capsule delivery technologies are expected to complement market growth. However, ethical issues, price variations in gelatin materials, and tight pharmaceutical sector regulations are projected to stymie market expansion.
Furthermore, the rising burden of chronic diseases, as well as the growing elderly population in the United States, are viewed as important drivers of market expansion. The number of Americans aged 65 and older is expected to nearly double from 52 million in 2018 to 95 million by 2060, according to the Population Reference Bureau's Population Bulletin-Aging in the United States. Similarly, 77% of Americans reported using dietary supplements, according to the CRN Consumer Survey on Dietary Supplements, 2019.
In addition, the survey found that vitamins and minerals were the most commonly consumed supplements by the American population in 2019, accounting for 76% of total dietary supplement consumption, followed by specialty supplements (40%), herbals, and botanicals (39%), sports nutrition supplements (28%), and weight management (17%). The rising prevalence of cardiovascular disorders around the world increases the demand for cardiovascular therapy medications for efficient treatment, driving market growth.
Several investments/guidelines in the market have been directed in recent years, which would boost the overall market. Some of them are:
Cardiovascular diseases (CVD) are quite common worldwide. According to the World Health Organization 2019, an estimated 17.9 million people die each year as a result of cardiovascular diseases worldwide, with the figure anticipated to rise to more than 23.6 million by 2030. Furthermore, according to the American Heart Association Research Report 2020, cardiovascular disease is the leading cause of death in the United States, accounting for almost 2,353 deaths each day, or one death every 37 seconds. In addition, according to the British Heart Foundation Centre, 7.6 million people in the United Kingdom were living with heart and circulation disorders in 2021. Each year, about 40,000 people under the age of 75 in the United Kingdom die from heart and circulation disorders.
Recent Developments
The market for empty capsules is highly competitive. To secure their positions in a competitive industry, important competitors are forming strategic alliances and launching new products. The market players are highly focused on mergers, expansions, and product approvals, to sustain in this market. Below are a few key developments:
In March 2021, CapsCanada, a Lyfe Group firm, announced the debut of a new liquid-filled hard capsule manufacturing service.
In August 2020, Dr. Reddy Laboratories acquired US Food and Drug Administration (USFDA) approval to launch generic Penicillamine capsules in the US market for the treatment of Wilson's disease and cystinuria.
In October 2020, Lonza invested CHF 85 million in its Capsules and Health Ingredients (CHI) division to increase its capsule manufacturing capacity by 30 billion capsules per year.
In April 2020, after negotiating agency and distribution partnership agreements with several market-leading organizations in the region, Qualicaps Europe established its presence in the Middle East and Africa.
In September 2019, Lupin got permission from Canada's health regulator for its Propranolol Hydrochloride extended-release capsules, which are intended to treat hypertension and reduce the frequency of angina attacks. Product approvals are also predicted to increase during the projection period, boosting the segment.
COVID-19 Impact
During the COVID-19 pandemic, the American College of Cardiology and the Canadian Cardiovascular Society issued guidelines for the reintroduction of cardiac services, such as home-based cardiac rehabilitation with exercise training and dietary counseling, medication management, tobacco cessation counseling, and psychosocial assessment interventions. As a result, the growing number of cardiac rehabilitation sessions is projected to boost the examined sector during the COVID-19 pandemic.
Segments Analysis
By Application Type
“The vitamin and dietary supplements segment is projected to dominate the global empty capsules market in 2021”.
The market is segmented into antibiotic and antibacterial drugs, vitamins and dietary supplements, antacid and antiflatulent preparations, cardiovascular therapy drugs, and others. In terms of application, the vitamin and dietary supplements segment was expected to account for the lion's share of the worldwide empty capsules market in 2021. During the forecast period, the sector is expected to dominate the global market.
The population's adoption of preventative care methods is expected to drive the vitamin & dietary supplements segment during the forecast period. Increased investment by key players in vitamin and dietary supplements, as well as favorable trade regulations for dietary supplement import and export, are expected to boost the vitamin and dietary supplements segment during the forecast period.
Want to get more details about the segmentations? Register Here
By Functionality Type
The empty capsules market has been divided into immediate-release capsules, delayed-release capsules, and sustained-release capsules.
By End-User Type
“The pharmaceutical industry segment is expected to grow rapidly during the forecast period”.
The market is segmented into the pharmaceutical industry, nutraceutical industry, cosmetics industry, research laboratories, and others. The pharmaceutical industry segment is predicted to rise rapidly over the forecast period due to the expansion of the pharmaceutical industry and the increased usage of capsules for various purposes.
Pharmaceuticals are the most common end-users of empty capsules (soft and hard capsules). The segment is being propelled by constant advancement in the pharmaceutical industry and frequent epidemics of chronic diseases around the world.
Regional Analysis
“North America holds a significant market share and is anticipated to continue this trend throughout the forecast period”.
The empty capsules market is broken down geographically into geographies, namely North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America has a sizable market share and is expected to maintain this trend over the forecast period.
Because of the growing inclination for capsule-based nutraceutical formulations, the area maintains a significant share. Consumption of these nutraceuticals has increased since they help avoid significant health concerns such as obesity, cancer, and arthritis. Furthermore, because capsules are the most popular solid oral dose forms, there is a strong need for empty capsules in the nutraceutical industry in the region.
Want to know which region offers the best growth opportunities?Register Here
Key Players
The following are the key players in the Empty Capsules Market (arranged alphabetically)
The overall competitive landscape has been affected due to major key factors.
Note: The above list does not necessarily include all the top players in the market.
Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
What Deliverables Will You Get in this Report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
In-depth Analysis of the Empty Capsules Market
How lucrative is the future?
The market forecast and trend data and emerging trends
Which regions offer the best sales opportunities?
Global, regional, and country-level historical data and forecasts
Which are the most attractive market segments?
Market segment analysis and Forecast
Which are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, Life cycle analysis
What are the factors affecting the market?
Drivers & challenges
Will I get the information on my specific requirement?
10% free customization
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.
We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.
Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to three players)
SWOT analysis of key players (up to three players)
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research:
Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
A rise in the popularity of capsules over other drug delivery forms and an increase in strategic alliances between empty capsule providers and gelatin manufacturers are major factors driving market expansion.
North America has a sizable market share and is expected to maintain this trend over the forecast period. Because of the growing inclination for capsule-based nutraceutical formulations, the area maintains a significant share.
The major players in the empty capsules market are ACG Worldwide, Lonza Group AG, Qualicaps, HealthCaps India Ltd., Natural Capsules Limited, CapsCanada Corporation, Roxlor, and Qingdao Yiqing Medicinal Capsules Co., Ltd.